Entelo, Inc.

SAN FRANCISCO, CA · Founded 2011 · CIK 0001619601 · Biotech

Biological platform for decoding human biology and developing medicines

entelo.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$4.9M
1 Form D · Sep 2014
145 months since last filing
Contracts
—
No federal contracts on record
Patents
12
3 granted · 9 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$4,927,487
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1837Superior Genomics, Inc.—$508K
1838CONCEPTION HOLDINGS, INC.—$50K
1839TRANSLATIONAL SCIENCES INC.——
1840Entelo, Inc.—$4.9M
1841KDAc Therapeutics, Inc.——
1842SCRIPT BIOSCIENCES INC——
1843HCO ANTIBODY, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 2 related persons
  • Jonathan BischkeDirector · Executive Officer
  • Roger LeeDirector

Patents

USPTO · 3 granted of 12

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.